Clinical trial
Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment…
NCT00422773 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00422773 |
|---|---|
| Title | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer |
| Official title | Open Labeled, Multicenter Phase I/II Study Evaluating the Dose Escalation/Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan as First-Line Treatment of Metastatic Colorectal Cancer |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 21 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2008 |
| First posted | Jan 17, 2007 |
| Last update posted | Feb 27, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: